Cargando…

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania

Background and objectives: The aim of this study was to analyze trends in testicular cancer incidence, mortality, and survival in Lithuania during the period 1998–2013. Materials and Methods: The study was based on all cases of testicular cancer reported to the Lithuanian Cancer Registry between 199...

Descripción completa

Detalles Bibliográficos
Autores principales: Drevinskaite, Mingaile, Patasius, Ausvydas, Kincius, Marius, Jievaltas, Mindaugas, Smailyte, Giedre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780107/
https://www.ncbi.nlm.nih.gov/pubmed/31480363
http://dx.doi.org/10.3390/medicina55090552
_version_ 1783457050523598848
author Drevinskaite, Mingaile
Patasius, Ausvydas
Kincius, Marius
Jievaltas, Mindaugas
Smailyte, Giedre
author_facet Drevinskaite, Mingaile
Patasius, Ausvydas
Kincius, Marius
Jievaltas, Mindaugas
Smailyte, Giedre
author_sort Drevinskaite, Mingaile
collection PubMed
description Background and objectives: The aim of this study was to analyze trends in testicular cancer incidence, mortality, and survival in Lithuania during the period 1998–2013. Materials and Methods: The study was based on all cases of testicular cancer reported to the Lithuanian Cancer Registry between 1998 and 2013. Age group-specific rates and standardized rates were calculated using the direct method (European standard population). The Joinpoint regression model was used to provide the annual percentage change (APC). Five-year relative survival estimates were calculated using period analysis. Relative survival was calculated as the ratio of the observed survival of cancer patients and the expected survival of the underlying general population. Results: During the study period, the age-standardized incidence rate of testicular cancer increased from 1.97 to 3.45 per 100,000, with APC of 2.97% (95% CI 0.9 to 5.1). Incidence rate of seminomas changed from 0.71 to 1.54 per 100,000, with APC of 2.61% (95% CI −0.4 to 5.7), and the incidence rate of non-seminomas increased from 0.84 to 1.83 per 100,000, with APC of 4.16% (95% CI 1.6 to 6.8). The mortality rate of testicular cancer in Lithuania during this period declined from 0.78 to 0.51 per 100,000, with APC of −2.91% (95% CI −5.5 to −0.3). Relative five-year survival ratio for the period 2009–2013 was 89.39% (95% CI 82.2 to 94.4). In our study, the overall five-year relative survival increased slightly (10.1%) from 2004–2008 to 2009–2013 (from 79.3% to 89.4%). Conclusions: A moderate increase of testicular cancer incidence has been observed in Lithuania between the years 1998 and 2013, while the mortality rate decreased. The five-year relative survival increased according to different period estimates; however, the results could have been higher if a multidisciplinary approach to diagnostics and management in the concerned centers had been implemented in Lithuania as in other countries.
format Online
Article
Text
id pubmed-6780107
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67801072019-10-30 A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania Drevinskaite, Mingaile Patasius, Ausvydas Kincius, Marius Jievaltas, Mindaugas Smailyte, Giedre Medicina (Kaunas) Article Background and objectives: The aim of this study was to analyze trends in testicular cancer incidence, mortality, and survival in Lithuania during the period 1998–2013. Materials and Methods: The study was based on all cases of testicular cancer reported to the Lithuanian Cancer Registry between 1998 and 2013. Age group-specific rates and standardized rates were calculated using the direct method (European standard population). The Joinpoint regression model was used to provide the annual percentage change (APC). Five-year relative survival estimates were calculated using period analysis. Relative survival was calculated as the ratio of the observed survival of cancer patients and the expected survival of the underlying general population. Results: During the study period, the age-standardized incidence rate of testicular cancer increased from 1.97 to 3.45 per 100,000, with APC of 2.97% (95% CI 0.9 to 5.1). Incidence rate of seminomas changed from 0.71 to 1.54 per 100,000, with APC of 2.61% (95% CI −0.4 to 5.7), and the incidence rate of non-seminomas increased from 0.84 to 1.83 per 100,000, with APC of 4.16% (95% CI 1.6 to 6.8). The mortality rate of testicular cancer in Lithuania during this period declined from 0.78 to 0.51 per 100,000, with APC of −2.91% (95% CI −5.5 to −0.3). Relative five-year survival ratio for the period 2009–2013 was 89.39% (95% CI 82.2 to 94.4). In our study, the overall five-year relative survival increased slightly (10.1%) from 2004–2008 to 2009–2013 (from 79.3% to 89.4%). Conclusions: A moderate increase of testicular cancer incidence has been observed in Lithuania between the years 1998 and 2013, while the mortality rate decreased. The five-year relative survival increased according to different period estimates; however, the results could have been higher if a multidisciplinary approach to diagnostics and management in the concerned centers had been implemented in Lithuania as in other countries. MDPI 2019-08-30 /pmc/articles/PMC6780107/ /pubmed/31480363 http://dx.doi.org/10.3390/medicina55090552 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Drevinskaite, Mingaile
Patasius, Ausvydas
Kincius, Marius
Jievaltas, Mindaugas
Smailyte, Giedre
A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title_full A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title_fullStr A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title_full_unstemmed A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title_short A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
title_sort population-based analysis of incidence, mortality, and survival in testicular cancer patients in lithuania
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780107/
https://www.ncbi.nlm.nih.gov/pubmed/31480363
http://dx.doi.org/10.3390/medicina55090552
work_keys_str_mv AT drevinskaitemingaile apopulationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT patasiusausvydas apopulationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT kinciusmarius apopulationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT jievaltasmindaugas apopulationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT smailytegiedre apopulationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT drevinskaitemingaile populationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT patasiusausvydas populationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT kinciusmarius populationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT jievaltasmindaugas populationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania
AT smailytegiedre populationbasedanalysisofincidencemortalityandsurvivalintesticularcancerpatientsinlithuania